0000880771-17-000003.txt : 20170105 0000880771-17-000003.hdr.sgml : 20170105 20170105185233 ACCESSION NUMBER: 0000880771-17-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170103 FILED AS OF DATE: 20170105 DATE AS OF CHANGE: 20170105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blobel Friedhelm CENTRAL INDEX KEY: 0001363213 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 17512404 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2017-01-03 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001363213 Blobel Friedhelm 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 1 1 0 0 President & CEO Common Stock 2017-01-03 4 M 0 300 1.81 A 87084 D Common Stock 2017-01-03 4 S 0 300 11 D 86784 D Common Stock 2017-01-04 4 M 0 100 1.81 A 86884 D Common Stock 2017-01-04 4 S 0 100 11 D 86784 D Common Stock 2017-01-05 4 M 0 9200 1.81 A 95984 D Common Stock 2017-01-05 4 S 0 9200 11.0204 D 86784 D Non-Qualified Stock Option (right to buy) 1.81 2017-01-03 4 M 0 300 0 D 2018-03-18 Common Stock 300 39700 D Non-Qualified Stock Option (right to buy) 1.81 2017-01-04 4 M 0 100 0 D 2018-03-18 Common Stock 100 39600 D Non-Qualified Stock Option (right to buy) 1.81 2017-01-05 4 M 0 9200 0 D 2018-03-18 Common Stock 9200 30400 D The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2016. Granted under the Issuer's 2005 Equity Incentive Plan. 1/36th of such shares will vest on June 1, 2010 and 1/36th will vest monthly thereafter over a three-year period, provided the reporting person remains employed by the Company. /s/ Wilson W. Cheung, Attorney-in-Fact for: Friedhelm Blobel 2017-01-05